| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.05. | Reports: Makary out, Diamantas in as FDA commissioner | ||
| 12.05. | Isomorphic raises $2.1bn for AI drug hunt | ||
| 12.05. | Boehringer, Brainomix plan new trial of lung fibrosis AI | ||
| 12.05. | EU agrees plan to tackle essential medicine shortages | ||
| 12.05. | Novo says high-dose Wegovy can cause 28% weight loss | ||
| 12.05. | BMS signs $15.2bn R&D alliance with China's Hengrui | ||
| 12.05. | Cellular Intelligence scoops up Novo's Parkinson's therapy | ||
| 11.05. | Novo Nordisk microRNA drug fluffs its lines in heart failure | ||
| 11.05. | GSK enlists local aid for Chinese rollout of hep B drug | ||
| 11.05. | Deal finally unlocks NHS access to ITF's Duchenne drug | ||
| 11.05. | Partner's Bizengri is first drug for rare, aggressive cancer | ||
| 11.05. | Is Makary on the way out, and who might replace him? | ||
| 08.05. | Capricor sues partner Nippon Shinyaku in DMD therapy spat | ||
| 08.05. | Eisai, Biogen face delay to subcutaneous Leqembi | ||
| 08.05. | J&J seeks to rewrite the script on depression treatment | ||
| 08.05. | Windward raises $165m for TSLP drug, and other biofinancings | ||
| 08.05. | Manufacturing hangover drives Daiichi Sankyo into the red | ||
| 07.05. | Bayer plans filings for cardiac amyloidosis imaging agent | ||
| 07.05. | Roche buys AI-powered diagnostics player PathAI | ||
| 07.05. | Mike Guarino appointed to lead EVERSANA INTOUCH | ||
| 07.05. | Angelini seeks US beachhead with $4.1bn Catalyst buy | ||
| 06.05. | Lilly inflates US facility investment spending by $4.5bn | ||
| 06.05. | CellCentric pockets $220m for blood cancer programme | ||
| 06.05. | BioNTech winds down COVID jab manufacturing, shedding staff | ||
| 06.05. | GSK bolts on siRNA drug from China's SiranBio in $1bn deal |